Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Grown Rogue International's
Operating Income
for the
three
months ended in Mar. 2026 was €0.09 Mil. Grown Rogue International's Interest Expense for the
three
months ended in Mar. 2026 was €-0.48 Mil.
Grown Rogue International's interest coverage for the quarter that ended in Mar. 2026 was 0.18.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Grown Rogue International's Interest Coverage or its related term are showing as below:
FRA:1VF0'
s Interest Coverage Range Over the Past 10 Years
Min: 1.12 Med: 1.61 Max: 5.18
Current: 1.12
FRA:1VF0's Interest Coverage is ranked worse than 92.29% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs FRA:1VF0: 1.12
Grown Rogue International (FRA:1VF0) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Grown Rogue International Interest Coverage Related Terms
Grown Rogue International Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:1VF0 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grown Rogue International Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Grown Rogue International's Interest Coverage falls into.
Grown Rogue International Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grown Rogue International (FRA:1VF0) has a Interest Coverage of 0.18 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grown Rogue International and its competitors. This is 89% below median its historical median of 1.61. Over the past decade, Grown Rogue International's Interest Coverage has ranged from 1.12 to 5.18. According to the industry distribution chart, Grown Rogue International ranks #634 out of 687 companies in the Drug Manufacturers industry, placing it in the top 92.3%.
Is Grown Rogue International's Interest Coverage too high?
Grown Rogue International's current Interest Coverage of 0.18 is 89% below median its 10-year median of 1.61. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 5.18. The Drug Manufacturers industry median Interest Coverage is 12.75. Grown Rogue International's value of 0.18 is 98.6% below this industry median. Based on the distribution chart, Grown Rogue International ranks #634 out of 687 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Grown Rogue International has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Grown Rogue International's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grown Rogue International ranks #634 out of 687 companies for Interest Coverage. This places Grown Rogue International in the lower half of its industry. The industry median Interest Coverage is 12.75. Grown Rogue International's value of 0.18 is 98.6% below this benchmark. Historically, Grown Rogue International's own Interest Coverage has ranged from 1.12 to 5.18 over the past decade. While the company's 10-year median is 1.61 vs. the industry median of 12.75, Grown Rogue International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grown Rogue International's current Interest Coverage of 0.18 is 98.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grown Rogue International and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grown Rogue International's current Interest Coverage is 0.18, which is 89% below median its own 10-year median of 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grown Rogue International stock overvalued right now?
Grown Rogue International (FRA:1VF0) has a current Interest Coverage of 0.18. The stock's GF Value™ is €0.40, compared to a current price of €0.36 — trading 10.5% below its estimated fair value. The current Interest Coverage is 0.18, which is 89% below median its 10-year median of 1.61 and 98.6% below the Drug Manufacturers industry median of 12.75. Grown Rogue International's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Grown Rogue International (FRA:1VF0), the current Interest Coverage is 0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grown Rogue International (FRA:1VF0) Overvalued in 2026?
Based on GuruFocus' analysis, Grown Rogue International stock appears to be undervalued.
The current stock price of €0.36 is trading 10.5% below its estimated GF Value™ of €0.40.
Key valuation signals for FRA:1VF0:
Interest Coverage: 0.18 (89% below median its 10-year median of 1.61)
GF Value™: €0.40 vs. price of €0.36 (10.5% below fair value)
Industry Position: 98.6% below the Drug Manufacturers median (#634 of 687)
No single metric tells the full story. See the FRA:1VF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States. The company has identified three operating segments: the Oregon segment represents cannabis production and sales activities in Oregon; the Michigan segment represents cannabis production and sales activities in Michigan; and the New Jersey segment represents cannabis production and sales activities in New Jersey.
49GF Score
Get the complete analysis for FRA:1VF0
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1VF0 has been successfully added to your 
